CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...